{name}
{subtitle}
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~17 mi. (St. Louis, Missouri, +523 more cities)
facility
Missouri Baptist Medical Center, +1 more facility
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~17 mi. (St. Louis, Missouri, +454 more cities)
facility
Cardinal Glennon Children's Medical Center, +5 more facilities
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~17 mi. (St. Louis, Missouri, +140 more cities)
facility
Saint Louis University ( Site 0769)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
city
~17 mi. (St. Louis, Missouri, +233 more cities)
facility
Mercy Hospital Saint Louis, +1 more facility
drug
degarelix, +4 more drugs
drug type
hormone therapy, +1 more type
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~17 mi. (St. Louis, Missouri, +127 more cities)
facility
Barnes- Jewish Hospital, +2 more facilities
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type